Rituximab as therapy for the recurrence of bile salt export pump deficiency after liver transplantation

Liver Transplantation

Volumn 19, Issue 12, 2013, Pages 1403-1410

  Lin, Henry C ^a   Alvarez, Luis ^b   Laroche, Greggy ^c   Melin Aldana, Hector ^a   Pfeifer, Kim ^c   Schwarz, Kathleen ^c   Whitington, Peter F ^a   Alonso, Estella M ^a   Ekong, Udeme D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; BILE SALT; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RITUXIMAB; TACROLIMUS; URSODEOXYCHOLIC ACID;

ARTICLE; BILE SALT EXPORT PUMP DEFICIENCY; CORTICOSTEROID THERAPY; END STAGE LIVER DISEASE; GRAFT DYSFUNCTION; GRAFT REJECTION; HEART ARREST; HUMAN; HUMAN TISSUE; INFANT; INTRAHEPATIC CHOLESTASIS; LIVER TRANSPLANTATION; MALE; MEDICAL DEVICE COMPLICATION; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 2; PUMP; RECURRENT DISEASE;

ANTIBODIES; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ATP-BINDING CASSETTE TRANSPORTERS; BIOPSY; CHOLESTASIS, INTRAHEPATIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INFANT; LIVER TRANSPLANTATION; MALE; PHENOTYPE; PLASMAPHERESIS; RECURRENCE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84889035195     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23754     Document Type: Article

References (15)

1. Shneider BL,. Progressive intrahepatic cholestasis: mechanisms, diagnosis and therapy. Pediatr Transplant 2004; 8: 609-612.
2. Arnell H, Papadogiannakis N, Zemack H, Knisely AS, Németh A, Fischler B,. Follow-up in children with progressive familial intrahepatic cholestasis after partial external biliary diversion. J Pediatr Gastroenterol Nutr 2010; 51: 494-499.
3. Englert C, Grabhorn E, Richter A, Rogiers X, Burdelski M, Ganschow R,. Liver transplantation in children with progressive familial intrahepatic cholestasis. Transplantation 2007; 84: 1361-1363.
4. Jankowska I, Socha P,. Progressive familial intrahepatic cholestasis and inborn errors of bile acid synthesis. Clin Res Hepatol Gastroenterol 2012; 36: 271-274.
5. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, et al. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20: 233-238.
6. Strautnieks SS, Byrne JA, Pawlikowska L, Cebecauerová D, Rayner A, Dutton L, et al. Severe bile salt export pump deficiency: 82 different ABCB11 mutations in 109 families. Gastroenterology 2008; 134: 1203-1214.
7. Byrne JA, Strautnieks SS, Ihrke G, Pagani F, Knisely AS, Linton KJ, et al. Missense mutations and single nucleotide polymorphisms in ABCB11 impair bile salt export pump processing and function or disrupt pre-messenger RNA splicing. Hepatology 2009; 49: 553-567.
8. Maggiore G, Gonzales E, Sciveres M, Redon MJ, Grosse B, Stieger B, et al. Relapsing features of bile salt export pump deficiency after liver transplantation in two patients with progressive familial intrahepatic cholestasis type 2. J Hepatol 2010; 53: 981-986.
9. Keitel V, Burdelski M, Vojnisek Z, Schmitt L, Häussinger D, Kubitz R,. De novo bile salt transporter antibodies as a possible cause of recurrent graft failure after liver transplantation: a novel mechanism of cholestasis. Hepatology 2009; 50: 510-517.
10. Jara P, Hierro L, Martínez-Fernández P, Alvarez-Doforno R, Yánez F, Diaz MC, et al. Recurrence of bile salt export pump deficiency after liver transplantation. N Engl J Med 2009; 361: 1359-1367.
11. Delacroix DL, Hodgson HJ, McPherson A, Dive C, Vaerman JP,. Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva. J Clin Invest 1982; 70: 230-241.
12. Mullock BM, Shaw LJ, Fitzharris B, Peppard J, Hamilton MJ, Simpson MT, et al. Sources of proteins in human bile. Gut 1985; 26: 500-509.
13. Siebold L, Dick AA, Thompson R, Maggiore G, Jacquemin E, Jaffe R, et al. Recurrent low gamma-glutamyl transpeptidase cholestasis following liver transplantation for bile salt export pump (BSEP) disease (posttransplant recurrent BSEP disease). Liver Transpl 2010; 16: 856-863.
14. Whitington PF, Whitington GL,. Partial external diversion of bile for the treatment of intractable pruritus associated with intrahepatic cholestasis. Gastroenterology 1988; 95: 130-136.
15. Schukfeh N, Metzelder ML, Petersen C, Reismann M, Pfister ED, Ure BM, Kuebler JF,. Normalization of serum bile acids after partial external biliary diversion indicates an excellent long-term outcome in children with progressive familial intrahepatic cholestasis. J Pediatr Surg 2012; 47: 501-505.